Searchable abstracts of presentations at key conferences in endocrinology

ea0020p293 | Clinical case reports and clinical reports | ECE2009

Prevalence and peculiarity of arterial hypertension treatment in acromegaly patients

Melnichenko Galina , Syirkin Abram , Pronin Vyachelav , Svet Alexey , Chaplyigina Ekaterina , Gitel Evgeniy , Poteshkin Yuriy

Occurrence of arterial hypertension (AH) in acromegaly (A) is the significant risk factor for sudden death. The study group included 232 patients with A aged 47–67 year (mean age 54). The duration of active phase of A was 7–17 years (median 11), GH levels were 23–19.2 ng/ml (mean 6.5), IGF-1 were 223–568 ng/ml (mean 354). AH was found in 186 patients (80.2%): 1st degree – 27%, 2nd – 32%, 3rd – 41%. Of 24-hour arterial blood pressure monitorin...